Cargando…
Targeting fatty acid metabolism in glioblastoma
Glioblastoma (GBM) is a primary tumor of the brain defined by its uniform lethality and resistance to conventional therapies. There have been considerable efforts to untangle the metabolic underpinnings of this disease to find novel therapeutic avenues for treatment. An emerging focus in this field...
Autores principales: | Miska, Jason, Chandel, Navdeep S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797338/ https://www.ncbi.nlm.nih.gov/pubmed/36594473 http://dx.doi.org/10.1172/JCI163448 |
Ejemplares similares
-
Fatty acid oxidation and photoreceptor metabolic needs
por: Fu, Zhongjie, et al.
Publicado: (2021) -
Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells
por: Caragher, Seamus, et al.
Publicado: (2020) -
Targeting glucose metabolism for cancer therapy
por: Hamanaka, Robert B., et al.
Publicado: (2012) -
Fundamentals of cancer metabolism
por: DeBerardinis, Ralph J., et al.
Publicado: (2016) -
HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
por: Miska, Jason, et al.
Publicado: (2019)